Gene: S100A11

6282
HEL-S-43|MLN70|S100C
S100 calcium binding protein A11
protein-coding
1q21.3
Ensembl:ENSG00000163191 MIM:603114 Vega:OTTHUMG00000013069 UniprotKB:P31949
NC_000001.11
PubMed
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
6.507e-1 (AD)  3.950e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CLIC10.935
IFI300.922
ARPC1B0.911
MYD880.907
ANXA20.907
CYBA0.903
VAMP80.903
GPSM30.902
LCP10.901
SPI10.897

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
MARCH4-0.554
SLC7A4-0.546
ABCC12-0.545
NEUROD6-0.535
PPEF1-0.529
CALHM1-0.514
ADRA1D-0.51
EXTL1-0.502
LRTM2-0.499
KCNB2-0.498

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB02482PhosphonothreonineSmall MoleculeExperimentalTarget
ID Drug Name Action PubMed
C0297902,2',3',4,4',5-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA"25510870
C0817662,4,4'-trichlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA"25510870
C0140242,4,5,2',4',5'-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA"25510870
C0098282,4,5,2',5'-pentachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA"25510870
C0094072,5,2',5'-tetrachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA"25510870
C0235142,6-dinitrotoluene"2,6-dinitrotoluene results in increased expression of S100A11 mRNA"20406850
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of S100A11 mRNA"18648102
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of S100A11 mRNA"25380136
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C0652504-hydroxy-equilenin4-hydroxy-equilenin results in increased expression of S100A11 mRNA15135645
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
D000082AcetaminophenAcetaminophen results in increased expression of S100A11 mRNA29067470
D000082AcetaminophenAcetaminophen affects the expression of S100A11 mRNA17562736
D000082AcetaminophenAcetaminophen results in increased expression of S100A11 mRNA24126418
D000111AcetylcysteineAcetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein]25940438
D000111AcetylcysteineAcetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein]25940438
D000111AcetylcysteineAcetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein]25940438
D020106AcrylamideAcrylamide results in decreased expression of S100A11 mRNA28959563
D016604Aflatoxin B1Aflatoxin B1 affects the expression of S100A11 protein20106945
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of S100A11 mRNA27153756
D000395Air Pollutants, Occupational"Air Pollutants, Occupational results in decreased expression of S100A11 mRNA"23195993
D013196DihydrotestosteroneDihydrotestosterone results in increased expression of S100A11 protein16751997
C059765amphotericin B, deoxycholate drug combination"amphotericin B, deoxycholate drug combination results in increased expression of S100A11 mRNA"22863853
D018501Antirheumatic AgentsAntirheumatic Agents results in decreased expression of S100A11 mRNA24449571
C081565arachidonyltrifluoromethanearachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to Cisplatin]25940438
C081565arachidonyltrifluoromethanearachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to oxaliplatin]25940438
D001151ArsenicArsenic affects the methylation of S100A11 gene25304211
C006632arsenic trioxidearsenic trioxide results in increased expression of S100A11 mRNA20458559
D001241AspirinAspirin results in decreased expression of S100A11 mRNA15928584
D001379AzathioprineAzathioprine results in increased expression of S100A11 mRNA22623647
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of S100A11 mRNA20106945|2163298
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of S100A11 mRNA19770486|2012785
C517629benzyloxycarbonyl-valyl-alanyl-aspartic acidbenzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein]25940438
C517629benzyloxycarbonyl-valyl-alanyl-aspartic acidbenzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein]25940438
D004958EstradiolEstradiol results in increased expression of S100A11 mRNA20106945
C006780bisphenol Abisphenol A results in decreased expression of S100A11 mRNA28780062
C006780bisphenol Abisphenol A affects the expression of S100A11 mRNA25181051
C006780bisphenol A[Fructose co-treated with bisphenol A] results in increased expression of S100A11 protein26930160
C423844BL 11282BL 11282 results in increased expression of S100A11 protein17458497
D001761BleomycinBleomycin results in increased expression of S100A11 protein25933445
D002104CadmiumCadmium results in increased oxidation of S100A11 protein24077948
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of S100A11 protein24419708
D019256Cadmium ChlorideCadmium Chloride results in increased expression of S100A11 protein24527689
D019256Cadmium ChlorideCadmium Chloride affects the expression of S100A11 mRNA22110744
D002220CarbamazepineCarbamazepine affects the expression of S100A11 mRNA25979313
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of S100A11 mRNA16239168
C043211carvedilolcarvedilol results in decreased expression of S100A11 protein20403466
D002392Catechin[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of S100A11 mRNA24763279
C100187chloropicrinchloropicrin results in increased expression of S100A11 mRNA26352163
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A11 mRNA20938992
C055162clopidogrelclopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of S100A11 mRNA]19172522
C018021cobaltous chloridecobaltous chloride results in decreased expression of S100A11 mRNA19376846
C018021cobaltous chloridecobaltous chloride results in increased expression of S100A11 mRNA24386269
D019327Copper SulfateCopper Sulfate results in increased expression of S100A11 mRNA19549813
D003471CuprizoneCuprizone results in increased expression of S100A11 mRNA26577399
C057862cyanoginosin LRcyanoginosin LR results in increased expression of S100A11 mRNA17654400
D016572CyclosporineCyclosporine results in increased expression of S100A11 mRNA20106945|2163298
C014347decitabinedecitabine affects the expression of S100A11 mRNA23300844
C014347decitabinedecitabine affects the methylation of S100A11 gene17579622
D003907DexamethasoneDexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of S100A11 mRNA]27941970
D003907DexamethasoneDexamethasone results in decreased expression of S100A11 mRNA22733784
C042577diallyl trisulfidediallyl trisulfide results in increased expression of S100A11 protein16344271
D002945CisplatinAcetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein]25940438
D002945CisplatinAcetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein]25940438
D002945CisplatinAcetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein]25940438
D002945Cisplatinarachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to Cisplatin]25940438
D002945Cisplatinbenzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein]25940438
D002945CisplatinCisplatin affects the expression of S100A11 mRNA23300844
D002945CisplatinS100A11 mutant form promotes the reaction [Cisplatin results in increased cleavage of PARP1 protein]25940438
D002945CisplatinS100A11 mutant form promotes the reaction [Cisplatin results in increased expression of H2AFX protein]25940438
D002945CisplatinS100A11 mutant form results in increased susceptibility to Cisplatin25940438
D002945Cisplatin[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein25940438
D002945Cisplatin[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein25940438
D002945Cisplatin[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein25940438
D004041Dietary FatsDietary Fats results in increased expression of S100A11 mRNA22609946|2501614
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of S100A11 mRNA24535843
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of S100A11 mRNA24535843
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of S100A11 mRNA19638242
D004128DimethylnitrosamineDimethylnitrosamine results in increased expression of S100A11 mRNA25380136
D004298DopamineDopamine results in increased expression of S100A11 mRNA21983523
D004317DoxorubicinDoxorubicin affects the expression of S100A11 protein29385562
D004791Enzyme Inhibitors[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of S100A11 protein23301498
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of S100A11 mRNA17942748
D004997Ethinyl Estradiol[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of S100A11 mRNA17942748
D018818FenoldopamFenoldopam results in increased expression of S100A11 mRNA21983523
D0150732-Acetylaminofluorene2-Acetylaminofluorene results in increased expression of S100A11 mRNA17317680
D005472Fluorouracilbenzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein]25940438
D005472FluorouracilS100A11 mutant form promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein]25940438
D005472FluorouracilS100A11 mutant form results in increased susceptibility to Fluorouracil25940438
D005472Fluorouracil[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased activity of CASP3 protein25940438
D005472Fluorouracil[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein25940438
D005472Fluorouracil[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased expression of H2AFX protein25940438
D005472FluorouracilFluorouracil results in increased expression of S100A11 mRNA19272435
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A11 mRNA20938992
D005632Fructose[Fructose co-treated with bisphenol A] results in increased expression of S100A11 protein26930160
C056933fumonisin B1fumonisin B1 results in increased expression of S100A11 mRNA16221962
C039281furanfuran results in increased expression of S100A11 mRNA26194646
D005839GentamicinsGentamicins results in increased expression of S100A11 mRNA22061828
D005897GlafenineGlafenine results in increased expression of S100A11 mRNA24136188
C511402Grape Seed Proanthocyanidins[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of S100A11 mRNA24763279
D006108GraphiteGraphite results in increased expression of S100A11 protein22157353
D017313FenretinideFenretinide results in decreased expression of S100A11 mRNA28973697
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased expression of S100A11 mRNA26846883
C492448ICG 001ICG 001 results in increased expression of S100A11 mRNA26191083
C016517indole-3-carbinolindole-3-carbinol affects the expression of S100A11 mRNA21396975
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of S100A11 mRNA25613284
D007545IsoproterenolIsoproterenol results in increased expression of S100A11 protein10886724
D007649KetamineKetamine results in decreased expression of S100A11 mRNA20080153
C029891lead chloridelead chloride results in increased expression of S100A11 protein24419708
C045463leflunomideleflunomide results in decreased expression of S100A11 mRNA24136188
C482199lipopolysaccharide, E coli O55-B5"lipopolysaccharide, E coli O55-B5 results in increased expression of S100A11 mRNA"24972896
C482199lipopolysaccharide, E coli O55-B5"[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of S100A11 mRNA"18930950
D008070Lipopolysaccharidesclopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of S100A11 mRNA]19172522
C042720mercuric bromidemercuric bromide results in increased expression of S100A11 mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
D008694Methamphetamine[Methamphetamine co-treated with SCH 23390] results in decreased expression of S100A11 mRNA19564919
D008694MethamphetamineMethamphetamine results in decreased expression of S100A11 mRNA19564919
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A11 mRNA20938992
D008727MethotrexateMethotrexate results in decreased expression of S100A11 mRNA17400583
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of S100A11 mRNA23458150
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of S100A11 mRNA23179753
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of S100A11 mRNA28001369
C045621miglitolmiglitol results in decreased expression of S100A11 mRNA20667563
D016685MitomycinS100A11 protein affects the susceptibility to Mitomycin16217747
C523799MRK 003S100A11 results in increased susceptibility to MRK 00319903844
D037742Nanotubes, Carbon"Nanotubes, Carbon affects the expression of S100A11 protein"22001959
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of S100A11 protein"22157353
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of S100A11 mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of S100A11 mRNA"25554681
D0150581-Naphthylisothiocyanate1-Naphthylisothiocyanate results in increased expression of S100A11 mRNA25380136
D009532NickelNickel results in decreased expression of S100A11 mRNA23195993
C030110oxaliplatinarachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to oxaliplatin]25940438
C030110oxaliplatinS100A11 mutant form results in increased susceptibility to oxaliplatin25940438
C030110oxaliplatin[S100A11 mutant form results in increased susceptibility to oxaliplatin] which results in increased activity of CASP3 protein25940438
C030110oxaliplatin[S100A11 mutant form results in increased susceptibility to oxaliplatin] which results in increased cleavage of PARP1 protein25940438
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of S100A11 mRNA26272509
C410127PCB 180"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA"25510870
D010634Phenobarbital[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of S100A11 mRNA24535843
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of S100A11 mRNA26272509
C006253pirinixic acid[pirinixic acid co-treated with PPARA] results in increased expression of S100A11 mRNA20813756
C006253pirinixic acidpirinixic acid results in decreased expression of S100A11 mRNA17426115
C006253pirinixic acidpirinixic acid results in increased expression of S100A11 mRNA16221962|2081375
C027373potassium chromate(VI)potassium chromate(VI) results in decreased expression of S100A11 mRNA22714537
D011441PropylthiouracilPropylthiouracil results in increased expression of S100A11 mRNA24780913
C513428pyrachlostrobinpyrachlostrobin results in increased expression of S100A11 mRNA27029645
D011794QuercetinQuercetin results in increased expression of S100A11 mRNA21632981
D012402RotenoneRotenone results in increased expression of S100A11 mRNA23186747
C534628SCH 23390[Methamphetamine co-treated with SCH 23390] results in decreased expression of S100A11 mRNA19564919
C534628SCH 23390SCH 23390 results in decreased expression of S100A11 mRNA19564919
D012643SeleniumSelenium results in increased expression of S100A11 mRNA19244175
D012715Sesame OilSesame Oil results in decreased expression of S100A11 mRNA29191790
D012822Silicon DioxideSilicon Dioxide results in increased expression of S100A11 mRNA23221170
D012969Sodium FluorideSodium Fluoride results in decreased expression of S100A11 protein28918527
D012969Sodium FluorideSodium Fluoride results in increased expression of S100A11 mRNA27862939
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of S100A11 mRNA20106945|2163298
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of S100A11 mRNA21570461
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of S100A11 mRNA17942748
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of S100A11 mRNA25613284
D013853ThioacetamideThioacetamide results in increased expression of S100A11 mRNA23411599
C009495titanium dioxidetitanium dioxide results in increased expression of S100A11 mRNA23557971|2776080
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of S100A11 mRNA28065790
D014212TretinoinTretinoin results in increased expression of S100A11 mRNA21934132
D014241TrichloroethyleneTrichloroethylene results in increased expression of S100A11 mRNA25549359
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of S100A11 mRNA24935251|2627250
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of S100A11 mRNA"26179874
C013320tris(2-butoxyethyl) phosphatetris(2-butoxyethyl) phosphate affects the expression of S100A11 mRNA29024780
C080163trovafloxacin"[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of S100A11 mRNA"18930950
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
D014635Valproic AcidValproic Acid results in decreased expression of S100A11 mRNA29154799
D014635Valproic AcidValproic Acid results in increased expression of S100A11 mRNA19101580|2317975
D014635Valproic AcidValproic Acid results in increased expression of S100A11 mRNA24896083
D014638VanadatesVanadates results in increased expression of S100A11 mRNA22714537
D014640VancomycinVancomycin results in decreased expression of S100A11 mRNA18930951
D001335Vehicle EmissionsVehicle Emissions results in increased methylation of S100A11 gene25560391
C025643vinclozolinvinclozolin affects the expression of S100A11 mRNA19015723
C029297vinylidene chloridevinylidene chloride results in increased expression of S100A11 mRNA26682919
D014810Vitamin EVitamin E results in increased expression of S100A11 mRNA19244175
C111237vorinostat"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA"27188386
C111237vorinostatvorinostat results in increased expression of S100A11 mRNA26272509

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005509calcium ion binding-IEA-  
GO:0005515protein binding-IPI10913138  
GO:0042803protein homodimerization activity-IDA10913138  
GO:0044548S100 protein binding-IPI10913138  
GO:0048306calcium-dependent protein binding-IDA10913138  
GO:0098641cadherin binding involved in cell-cell adhesion-HDA25468996  
GO ID GO Term Qualifier Evidence PubMed
GO:0007165signal transduction-TAS16130169  
GO:0008156negative regulation of DNA replication-TAS10851017  
GO:0008285negative regulation of cell proliferation-TAS10851017  
GO:0043312neutrophil degranulation-TAS-  
GO:0098609cell-cell adhesion-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0001726ruffle-IDA10913138  
GO:0005576extracellular region-HDA27068509  
GO:0005576extracellular region-TAS-  
GO:0005615extracellular space-HDA16502470  23580065  
GO:0005634nucleus-IDA10913138  
GO:0005737cytoplasm-IDA10913138  
GO:0005737cytoplasm-TAS16130169  
GO:0005913cell-cell adherens junction-HDA25468996  
GO:0034774secretory granule lumen-TAS-  
GO:0070062extracellular exosome-HDA19199708  23533145  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-168249Innate Immune SystemTAS
R-HSA-168256Immune SystemTAS
R-HSA-6798695Neutrophil degranulationTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
28652369Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival. (2017 Jul 11)Gocheva VProc Natl Acad Sci U S A